Carmell Therapeutics Corporation

Carmell Therapeutics Corporation - ROEverified

CTCX

Price:

$0.1973

Market Cap:

$243.03K

Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the comp...[Read more]

Industry

Biotechnology

IPO Date

2021-09-23

Stock Exchange

NASDAQ

Ticker

CTCX

The ROE as of September 2026 (TTM) for Carmell Therapeutics Corporation (CTCX) is 107.36%

According to Carmell Therapeutics Corporation’s latest financial reports and current stock price. The company's current ROE is 107.36%. This represents a change of 277.15% compared to the average of 28.47% of the last 4 quarters.

Carmell Therapeutics Corporation (CTCX) Historical ROE (quarterly & annually)

How has CTCX ROE performed in the past?

The mean historical ROE of Carmell Therapeutics Corporation over the last ten years is 64.23%. The current 107.36% ROE has changed 67.15% with respect to the historical average. Over the past ten years (40 quarters), CTCX's ROE was at its highest in in the June 2024 quarter at 240.90%. The ROE was at its lowest in in the September 2023 quarter at -54.81%.

Quarterly (TTM)
Annual

Average

64.23%

Median

23.95%

Minimum

-62.41%

Maximum

220.01%

Carmell Therapeutics Corporation (CTCX) ROE by Quarter and Year

Discovering the peaks and valleys of Carmell Therapeutics Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 9.34%

Maximum Annual ROE = 220.01%

Minimum Annual Increase = -452.54%

Minimum Annual ROE = -62.41%

Quarterly (TTM)
Annual
YearROEChange
2025117.70%-46.50%
2024220.01%-452.54%
2023-62.41%-360.56%
202223.95%9.34%

Carmell Therapeutics Corporation (CTCX) Average ROE

How has CTCX ROE performed in the past?

The current ROE of Carmell Therapeutics Corporation (CTCX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

91.77%

5-year avg

64.23%

10-year avg

64.23%

Carmell Therapeutics Corporation (CTCX) ROE vs. Peers

How is CTCX’s ROE compared to its peers?

Carmell Therapeutics Corporation’s ROE is greater than Tricida, Inc. (-355.98%), greater than Entero Therapeutics, Inc. (-55.12%), greater than Tectonic Therapeutic, Inc. (-35.26%), greater than Fresh Tracks Therapeutics, Inc. (-66.50%), greater than Xenetic Biosciences, Inc. (-40.62%), greater than Neuphoria Therapeutics Inc. (-77.03%), greater than BiondVax Pharmaceuticals Ltd. (-4.92%), less than Kineta, Inc. (374.84%), greater than Nabriva Therapeutics plc (-201.91%), less than ModivCare Inc. (135.85%),

Build a custom stock screener for Carmell Therapeutics Corporation (CTCX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Carmell Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Carmell Therapeutics Corporation (CTCX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Carmell Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Carmell Therapeutics Corporation's ROE?

How is the ROE calculated for Carmell Therapeutics Corporation (CTCX)?

What is the highest ROE for Carmell Therapeutics Corporation (CTCX)?

What is the 3-year average ROE for Carmell Therapeutics Corporation (CTCX)?

What is the 5-year average ROE for Carmell Therapeutics Corporation (CTCX)?

How does the current ROE for Carmell Therapeutics Corporation (CTCX) compare to its historical average?